The Acne Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase.
The report also covers a detailed description of the drug including mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.
The report provides insights into:
-
The report provides detailed insights about companies that are developing therapies for the treatment of Acne with aggregate therapies developed by each company for the same.
-
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for the Acne Treatment.
-
Acne key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
-
Acne Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
-
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Acne market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample Pages @ https://www.delveinsight.com/sample-request/acne-pipeline-insight
Acne Therapeutics Landscape
Companies across the globe are diligently working toward the development of novel treatment therapies for Acne with a considerable amount of success over the years. The launch of the emerging therapies is expected to change the treatment dynamics in the coming years.
Key companies in the Acne Market include:
-
Sol-Gel Technologies
-
Botanix Pharmaceuticals
-
Novartis Pharmaceuticals
Acne Therapies covered in the report includes -
BTX1503 - Botanix Pharmaceuticals is working on BTX1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers. Phase II trial of the drug has been completed. Phase III trial design is being finalized as per the latest updates by the company.
Twyneo - Twyneo is an investigational, antibiotic-free, fixed-dose combination of benzoyl peroxide, 3%, and tretinoin, 0.1%, cream for the treatment of acne vulgaris, using their proprietary drug-delivery technology. The FDA has accepted the NDA for Twyneo with a PDUFA goal date set for August 1, 2021.
LYS006 - LYS006 is an orally administered small molecule, leukotriene A4 (LTA4) hydrolase inhibitor being developed by Novartis, for the treatment of moderate to severe inflammatory acne. A phase II trial is ongoing with 56 participants which is anticipated to get completed by April 2022.
The launch of emerging products will significantly impact the Acne market in the coming years.
Request for Sample Pages @ https://www.delveinsight.com/sample-request/acne-pipeline-insight
Table of Content
1. Report Introduction
2. Acne
3. Acne Current Treatment Patterns
4. Acne - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acne Late Stage Products (Phase-III)
7. Acne Mid Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acne Discontinued Products
13. Acne Product Profiles
14. Acne Key Companies
15. Acne Key Products
16. Dormant and Discontinued Products
17. Acne Unmet Needs
18. Acne Future Perspectives
19. Acne Analyst Review
20. Appendix
21. Report Methodology
*The table of contents is not exhaustive; the final content may vary.
Visit to get the sample report: https://www.delveinsight.com/sample-request/acne-pipeline-insight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
